What is Microvi Biotech?
Microvi Biotech, headquartered in Hayward, California, is at the forefront of developing advanced solutions for clean drinking water. The company specializes in nitrate removal and filtration technologies, addressing critical global water quality challenges. Beyond its product offerings, Microvi Biotech actively engages in research and facilitates case studies to advance the understanding and application of water filtration methodologies. Its focus on essential water purification technologies positions it as a key player in the environmental technology and biotech industries.
How much funding has Microvi Biotech raised?
Microvi Biotech has raised a total of $1.4M across 3 funding rounds:
Series A
$1M
Debt
$150K
Debt
$217K
Series A (2009): $1M with participation from Perry Solomon
Debt (2020): $150K led by PPP
Debt (2021): $217K supported by PPP
Key Investors in Microvi Biotech
Perry Solomon
Perry Solomon is an individual investor who participated in Microvi Biotech's Series A funding round. Their involvement suggests a belief in the company's early-stage potential and its mission to provide clean water solutions.
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for Microvi Biotech?
The substantial enterprise-level funding and recent strategic investment suggest Microvi Biotech is poised for significant expansion. This capital infusion is likely to accelerate product development, enhance manufacturing capabilities, and broaden market reach, particularly in regions facing water scarcity and contamination issues. The company's trajectory indicates a move towards scaling its operations to meet growing demand for effective and sustainable water treatment solutions. Future growth may involve strategic partnerships and further technological innovation to solidify its market leadership.
See full Microvi Biotech company page
